Trial Profile
Lot-to-Lot Consistency, Bridging, and Safety Trial of ChimeriVax -Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary) ; Hepatitis A vaccine inactivated
- Indications Hepatitis A; Japanese encephalitis
- Focus Pharmacodynamics; Registrational
- Sponsors Sanofi; Sanofi Pasteur
- 14 Aug 2014 According to ClinicalTrials.gov record, additional secondary endpoints added.
- 28 Oct 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 28 Oct 2009 Actual patient number (1199) added as reported by ClinicalTrials.gov.